GFAP and Alzheimer disease: This study provides evidence that plasma biomarkers associated with AD pathophysiology, including Aβ42/40 and pTau-181, and biomarkers of broader neurodegenerative processes (NfL and GFAP) are associated with cognitive performance among middle-aged and older Hispanic/Latino adults.